Quick Takeaways: Why It Matters? PetVivo’s preliminary macaque studies add early evidence for Spryng’s potential in osteoarthritis management, combining mobility improvements with encouraging local tissue-response findings. The data could support further development of its inje...
Quick Takeaways: Why It Matters? The strong equine proof‑of‑concept data, clean safety profile, and upcoming human knee OA feasibility study collectively de‑risk Hydrocelin’s translational path, increasing its attractiveness as a first‑in‑class, potentially disease‑mo...
